Skip to main content
Have a personal or library account? Click to login
Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity Cover

Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity

Radiology and Oncology
Volume 46 (2012): Issue 4 (December 2012)
By: ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|Nov 2012
References

References

  1. 1. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours.2008;232-40.
    Open DOISearch in Google Scholar
  2. 2. Kranjc S, Tevz G, Kamensek U, Vidic S, Cemazar M, Sersa G. Radiosensitizing effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model.2009;677-85.
    Open DOISearch in Google Scholar
  3. 3. Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, et al. Electrochemotherapy: a new technological approach in treatment of metastases in the liver.2011;475-85.
    Open DOISearch in Google Scholar
  4. 4. Heller R, Gilbert R, Jaroszeski MJ. Clinical trials for solid tumors using electrochemotherapy.2000;137-56.
    Open DOISearch in Google Scholar
  5. 5. Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, et al. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy.10
    Open DOISearch in Google Scholar
  6. 6. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients.2000;863-7.
    Search in Google Scholar
  7. 7. Cutrera J, Torrero M, Shiomitsu K, Mauldin N, Li S. Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.2008;319-25.
    Open DOISearch in Google Scholar
  8. 8. Heller L, Pottinger C, Jaroszeski MJ, Gilbert R, Heller R. In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity.2000;577-83.
    Open DOISearch in Google Scholar
  9. 9. Sersa G, Cemazar M, Menart V, Gaberc-Porekar V, Miklavcic D. Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNFalpha on SA-1 tumors in mice.1997;85-92.
    Open DOISearch in Google Scholar
  10. 10. Torrero M, Li S. Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination.2008;339-49.
    Open DOISearch in Google Scholar
  11. 11. Torrero MN, Henk WG, Li S. Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy.2006;257-63.
    Open DOISearch in Google Scholar
  12. 12. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek J, Jr., et al. Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2.1995;30-8.
    Open DOISearch in Google Scholar
  13. 13. Kishida T, Asada H, Itokawa Y, Yasutomi K, Shin-Ya M, Gojo S, et al. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.2003;738-45.
    Open DOISearch in Google Scholar
  14. 14. Orlowski S, An D, Belehradek J, Jr., Mir LM. Antimetastatic effects of electrochemotherapy and of histoincompatible interleukin-2-secreting cells in the murine Lewis lung tumor.1998;551-6.
    Open DOISearch in Google Scholar
  15. 15. Ramirez LH, Orlowski S, An D, Bindoula G, Dzodic R, Ardouin P, et al. Electrochemotherapy on liver tumours in rabbits.1998;2104-11.
    Open DOISearch in Google Scholar
  16. 16. Andersen MH, Gehl J, Reker S, Geertsen P, Becker JC, thor Stratem P. Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil?2005;5265-7.
    Search in Google Scholar
  17. 17. Mir LM, Orlowski S, Poddevin B, Belehradek J, Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host’s defenses.1992;331-4.
    Search in Google Scholar
  18. 18. Andersen MH, Gehl J, Reker S, Pedersen LO, Becker JC, Geertsen P, et al. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.2003;449-59.
    Open DOISearch in Google Scholar
  19. 19. Cemazar M, Sersa G, Pavlin D, Tozon N. Intramuscular IL-12 Electrogene Therapy for Treatment of Spontaneous Canine Tumors. In: You Y, editor.. InTech; 2011. p. 299 - 320.
    Open DOISearch in Google Scholar
  20. 20. Cemazar M, Jarm T, Sersa G. Cancer electrogene therapy with interleukin-12.2010;300-11.
    Open DOISearch in Google Scholar
  21. 21. Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G, Atkins MB, et al. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.1997;2541-8.
    Search in Google Scholar
  22. 22. Kang WK, Park C, Yoon HL, Kim WS, Yoon SS, Lee MH, et al. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study.2001;671-84.
    Open DOISearch in Google Scholar
  23. 23. Mazzolini G, Prieto J, Melero I. Gene therapy of cancer with interleukin-12.2003;1981-91.
    Open DOISearch in Google Scholar
  24. 24. Prijic S, Prosen L, Cemazar M, Scancar J, Romih R, Lavrencak J, et al. Surface modified magnetic nanoparticles for immuno-gene therapy of murine mammary adenocarcinoma.2012;4379-91.
    Open DOISearch in Google Scholar
  25. 25. Sangro B, Melero I, Qian C, Prieto J. Gene therapy of cancer based on interleukin 12.2005;573-81.
    Open DOISearch in Google Scholar
  26. 26. Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.2008;5896-903.
    Open DOISearch in Google Scholar
  27. 27. Heller LC, Heller R. Electroporation gene therapy preclinical and clinical trials for melanoma.2010;312-7.
    Open DOISearch in Google Scholar
  28. 28. Teissie J, Escoffre JM, Paganin A, Chabot S, Bellard E, Wasungu L, et al. Drug delivery by electropulsation: Recent developments in oncology.2012;3-6.
    Open DOISearch in Google Scholar
  29. 29. Pavlin D, Cemazar M, Coer A, Sersa G, Pogacnik A, Tozon N. Electrogene therapy with interleukin-12 in canine mast cell tumors.2011;31-9.
    Open DOISearch in Google Scholar
  30. 30. Markelc B, Bellard E, Sersa G, Pelofy S, Teissie J, Coer A, et al. In vivo molecular imaging and histological analysis of changes induced by electric pulses used for plasmid DNA electrotransfer to the skin: A study in a dorsal window chamber in mice.2012;545-54.
    Open DOISearch in Google Scholar
  31. 31. Rebersek M, Cufer T, Cemazar M, Kranjc S, Sersa G. Electrochemotherapy with cisplatin of cutaneous tumor lesions in breast cancer.2004;593-7.
    Open DOISearch in Google Scholar
  32. 32. Sersa G, Stabuc B, Cemazar M, Jancar B, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients.1998;1213-8.
    Open DOISearch in Google Scholar
  33. 33. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases.2000;381-5.
    Open DOISearch in Google Scholar
  34. 34. Tamzali Y, Borde L, Rols MP, Golzio M, Lyazrhi F, Teissie J. Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases.2012;214-20.
    Open DOISearch in Google Scholar
  35. 35. Spugnini EP, Vincenzi B, Citro G, Dotsinsky I, Mudrov T, Baldi A. Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs.2011;407-11.
    Open DOISearch in Google Scholar
  36. 36. Tozon N, Sersa G, Cemazar M. Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats.2001;2483-8.
    Search in Google Scholar
  37. 37. Cemazar M, Pavlin D, Sersa G, Tozon N.In: Proceedings of the Fundamental & Applied Bioelectrics, 23-27th 2012 Norfolk, USA: an international scientific workshop. Norfolk: Old Dominion University, 2012, 94-9.
    Search in Google Scholar
  38. 38. Nanni P, de Giovanni C, Lollini PL, Nicoletti G, Prodi G. TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma.1983;373-80.
    Open DOISearch in Google Scholar
  39. 39. North RJ, Neubauer RH, Huang JJ, Newton RC, Loveless SE. Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity.1988;2031-43.
    Open DOISearch in Google Scholar
  40. 40. Rakhmilevich AL, Janssen K, Hao ZL, Sondel PM, Yang NS. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.2000;826-38.
    Open DOISearch in Google Scholar
  41. 41. Oshikawa K, Shi FS, Rakhmilevich AL, Sondel PM, Mahvi DM, Yang NS. Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1 beta converting enzyme cDNA.1999;13351-6.
    Open DOISearch in Google Scholar
  42. 42. Di Carlo E, Cappello P, Sorrentino C, D’Antuono T, Pellicciotta A, Giovarelli M, et al. Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway.2005;82-91.
    Open DOISearch in Google Scholar
  43. 43. Allione A, Consalvo M, Nanni P, Lollini PL, Cavallo F, Giovarelli M, et al. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.1994;6022-6.
    Search in Google Scholar
  44. 44. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, et al. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin.2002;1047-54.
    Open DOISearch in Google Scholar
  45. 45. Marty M, Sersa G, Garbay J, Gehl J, Collins C, Snoj M, et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study.2006;3-13.
    Open DOISearch in Google Scholar
  46. 46. Cemazar M, Milacic R, Miklavcic D, Dolzan V, Sersa G. Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content.1998;525-30.
    Open DOISearch in Google Scholar
  47. 47. Tevz G, Pavlin D, Kamensek U, Kranjc S, Mesojednik S, Coer A, et al. Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression.2008;91-101.
    Open DOISearch in Google Scholar
  48. 48. Tevz G, Kranjc S, Cemazar M, Kamensek U, Coer A, Krzan M, et al. Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas.2009;1125-37.
    Open DOISearch in Google Scholar
  49. 49. Corbett TH, Valeriote FA. Rodent models in experimental chemotherapy. In: Kallman RF, editor.. New York: Pergamon Press; 1987. p. 233-47.
    Search in Google Scholar
  50. 50. Sersa G, Cufer T, Paulin SM, Cemazar M, Snoj M. Electrochemotherapy of chest wall breast cancer recurrence.2012;379-86.
    Open DOISearch in Google Scholar
  51. 51. Cemazar M, Miklavcic D, Sersa G. Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy.1998;328-33.
    Open DOISearch in Google Scholar
  52. 52. Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice.1995;3450-5.
    Search in Google Scholar
  53. 53. Mali B, Jarm T, Snoj M, Sersa G, Miklavcic D. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis.2012, http://dx.doi.org/10.1016/j.ejso.2012.08.016;
    Search in Google Scholar
  54. 54. Sersa G, Kotnik V, Cemazar M, Miklavcic D, Kotnik A. Electrochemotherapy with bleomycin in SA-1 tumor-bearing mice--natural resistance and immune responsiveness.1996;785-91.
    Open DOISearch in Google Scholar
  55. 55. Sersa G, Cemazar M, Miklavcic D, Mir LM. Electrochemotherapy: variable anti-tumor effect on different tumor models.1994;83-7.
    Search in Google Scholar
  56. 56. Sersa G, Miklavcic D, Cemazar M, Belehradek J, Jr., Jarm T, Mir LM. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompetent and immunodeficient mice.1997;279-83.
    Open DOISearch in Google Scholar
  57. 57. Cemazar M, Miklavcic D, Mir LM, Belehradek J, Jr., Bonnay M, Fourcault D, et al. Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model.2001;1166-72.
    Open DOISearch in Google Scholar
  58. 58. Orlowski S, Belehradek J, Jr., Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs.1988;4727-33.
    Open DOISearch in Google Scholar
  59. 59. Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma.2008;388-98.
    Open DOISearch in Google Scholar
  60. 60. Corovic S, Mir LM, Miklavcic D. In vivo muscle electroporation threshold determination: realistic numerical models and in vivo experiments.2012;509-20..
    Open DOISearch in Google Scholar
  61. 61. Quaglino P, Osella-Abate S, Marenco F, Nardo T, Gado C, Novelli M, et al. FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy.2011;734-6.
    Open DOISearch in Google Scholar
  62. 62. Mir LM, Roth C, Orlowski S, Belehradek J, Jr., Fradelizi D, Paoletti C, et al. [Potentiation of the antitumoral effect of electrochemotherapy by immunotherapy with allogeneic cells producing interleukin 2].1992;539-44.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10019-012-0044-9 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 302 - 311
Submitted on: Jul 21, 2012
Accepted on: Aug 15, 2012
Published on: Nov 9, 2012
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
IL-12,
gene electrotransfer,
cisplatin,
electrochemotherapy,
sarcoma,
carcinoma,
mice
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2012 Ales Sedlar, Tanja Dolinsek, Bostjan Markelc, Lara Prosen, Simona Kranjc, Masa Bosnjak, Tanja Blagus, Maja Cemazar, Gregor Sersa, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 46 (2012): Issue 4 (December 2012)
Previous article
Next article